A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...
The Chosun Ilbo on MSN
Global pharma, Korean firms race in dementia drug development
U.S. pharmaceutical company Eli Lilly plans to disclose the topline results of its phase 3 clinical trial for remternemab, a new drug candidate developed as a successor to its Alzheimer’s treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback